Registration
ARENTFOX SCHIFF LLP for PINNACLE BIOLOGICS, INC.
Firm
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Calendar Year 2026 Hospital Outpatient Prospective Payment System proposed rule regarding Medicare coverage for a Pinnacle biologic product
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAN RENBERG New | Member, Board of Directors, Ex-Im Bank (1999-2003); Leg. Director and Dep. Chief of Staff, Sen. Arlen Specter (1994-1998) |
| BLAKE THELANDER New | Health Policy Advisor/Legislative Director, Rep. Mariannette Miller-Meeks (2023-2025), Staff Assistant/Legislative Assistant/Senior Legislative Assistant, Rep. Jefferson Van Drew (2020-2023), Intern, Rep. Ralph Norman (2019-2019) |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NORDIC CAPITAL LIMITED (PER FUND X) | Jersey | Jersey | 98.9% | — |
| ADVANZ PHARMA HOLDCO LIMITED | Jersey | Jersey | 100.0% | — |
| CIDRON AIDA LIMITED | Jersey | Jersey | 98.9% | — |
| ADVANZ PHARMA CORP. LIMITED | Jersey | Jersey | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.